HOW TO ASSESS COMORBIDITY OF PATIENTS SUFFERING FROM HIP FRACTURE ASSOCIATED WITH OSTEOPOROSIS AND SUBSEQUENT HIP REPLACEMENT

Golovach I.Yu.¹, Zazirniy I.M.¹, Turovskaya T.V.², Semeniv I.P. ¹, Yevseenko V.G.³, Chipko T.M. ¹, Pinchuk Ye.I.³, Yurchenko S.A.³, Lazorenko E.A.¹

• ¹Feofaniya Clinical Hospital, Kyiv
• ²Донецкий медицинский университет им. Максима Горького
• ³Клінічна лікарня «Феофанія» ДУС, Київ

Summary. Summary. The article is devoted to the establishment of comorbidity of patients with an osteoporotic hip fracture who subsequently underwent hip replacement. Retrospective analysis was applied to the research of 60 cases of osteoporotic hip fractures; the patients’ average age was 77.9±9.2 years. Fragility fractures were confirmed by Dual-energy X-ray absorptiometry. Out 37 patients participating in the research 32 were diagnosed with osteoporosis, other 5 patients — with the III degree osteopenic syndrome. All patients had a high comorbidity index: the Charleston’ comorbidity index was 8.66±1.92 points, CIRS comorbidity index — 12.4±4.8 points. The disturbances of cardiovascular system accounted for the largest share of comorbidity structure, first of all coronary heart disease, hypertension, heart rhythm disturbance, leading to congestive heart failure, and vascular disease of the central nervous system as well. The older were the patients, the higher was comorbidity indexes accompanied by worse concomitant diseases and increased risk of complications. Severity of comorbidity and comorbidity index’ values significantly influenced the choice of surgical treatment for hip fracture.